
Cancer Research KI
Cancer Research KI is an overarching umbrella organisation of cancer research at 探花精选, that includes more than 350 research groups. The aim is to combine cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines, with the goal to aid generating new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.
The Cancer Research KI missions
Educating
News

Cancer Research KI PI Retreat 2025 Recap
During February 17th and 18th, 80 principal investigators from 13 departments at KI, both from the Solna and Flemingsberg campuses, participated in the Cancer Research KI PI Retreat in Djur枚n盲set. The participating researchers covered pre-clinical, translational, clinical, and epidemiological research areas. The event featured research presentations, elevator pitches, and, for the first time this year, a session on Personalized Cancer Medicine and Clinical Trials, followed by a panel discussion. Additionally, a Fast-Track Collaboration Challenge was held to foster new collaborations among the participating PIs.

En dag f枚r cancerforskning 2024
Watch the recordings of En dag f枚r cancerforskning 2024 here.

Prestigious G枚ran Gustafsson Prize to Laura Baranello
Laura Baranello, principal researcher at the Department of Cell and Molecular Biology at 探花精选, receives the G枚ran Gustafsson Prize in molecular biology. The goal of her research is to find a new strategy for gentler cancer treatments. The idea is to improve both survival and quality of life for patients in the future.
"The biggest challenge today with chemotherapy is that the drugs cannot distinguish between cancer cells and fast-growing healthy cells. This means that doctors sometimes hesitate to start treatment because the patient suffers from so many side effects. Our goal is to achieve a greater understanding of the molecular mechanism of the topoisomerases in cancer cells using a combination of genomics and molecular biology approaches".

Dan Grand茅r Research Prize
The Dan Grand茅r Research Prize is awarded annually for the best dissertation in cancer research at 探花精选.
Nomination for 2024 year's award is open until March 31st 2025.

2024 Blue Sky grant recipients
Congratulations to the Blue Sky grant recipients of 2024:
Claudia Kutter, Erdinc Sezgin, Joel Rurik, Kimmo Kartasalo, Lisa Westerberg, Niklas Bj枚rkstr枚m, Oliver Mortusewicz, Qiang Pan Hammarstr枚m, Roland Fiskesund, and Tom Erkers

Thuy Tran receives grant from Erling-Persson Foundation to develop method for hard-to-treat cancer
Thuy Tran鈥檚 research group has been awarded 8 million SEK over three years from the Erling-Persson Foundation to develop a precision-focused, theranostic method that integrates both diagnostics and treatment of advanced solid tumors. Thuy Tran鈥檚 research focuses on creating an innovative, targeted platform that aims to provide less invasive, personalized, and targeted treatment options. The goal is to improve both patient well-being and treatment outcomes.

Two innovation environments at KI win Vinnova grants
Vinnova is investing in precision medicine and awarding grant funding to six innovation environments. Two of them are at 探花精选, and both focus on treating cancer. The aim of the grants is to fund efforts to bring greater precision to the diagnosis and treatment of common diseases.

Cancer Research at Almedalen Week 2024
Cancer Research KI (CRKI), the Karolinska Comprehensive Cancer Center (KCCC), and the Precision Medicine Center Karolinska (PMCK) held seminars on precision medicine during Almedalen Week 2024.

Theranostics Trial Center receives 15 million SEK for large investment in precision medicine
Theranostics Trial Center (TTC) at 探花精选 and Karolinska University Hospital has received a significant grant of more than 15 million SEK from Vinnova to run a new project within precision medicine. By combining image-guided diagnostics and therapy with radioactively labelled targeted drugs, the project aims to revolutionize cancer treatment in Sweden. TTC is one of six new innovation environments receiving funding from Vinnova.

Grant from the Sj枚berg Foundation to Hildur Helgadottir
Hildur Helgadottir receives project funding from the Sj枚berg Foundation of totally 21 million SEK divided over three years. The funding supports the project 鈥淣EO-TIL: A Multicenter Clinical Initiative Conducted by the Swedish Melanoma Study Group鈥. Co-applicants are Stina Wickstr枚m, also at OnkPat, and G枚ran J枚nsson and Ana Carneiro at Lund University and Lars Ny, Roger Olofsson Bagge and Jonas Nilsson at University of Gothenburg.

Jonas Bergh receives the Grand Silver Medal 2024
Professor Jonas Bergh receives the Grand Silver Medal for his world-leading and unique contributions to cancer research at 探花精选. The medal has been presented since 2010 to individuals who have made tremendous efforts to support the activities of KI and is recognized during the installation ceremony at Aula Medica on October 3.

Prevention plays a crucial role in the fight against cancer
Read about Karolinska CCC Day 2024, which took place on April 12 and focused on prevention.

Recap of Cancer Research KI, PI-Retreat 2024
From February 19th to 20th, 2024, Cancer Research KI hosted its first PI-Retreat, bringing together Principal Investigators (PIs) and group leaders engaged in cancer research at KI. The event aimed to foster extensive networking opportunities within the cancer research domain, broaden scientific perspectives, and catalyze collaborative efforts and funding ventures.

Recap from Karolinska CCC re-accreditation kick-off
In preparation for the re-accreditation according to the Organisation of European Cancer Institutes (OECI), a kick-off was held on 6 September at the Karolinska Comprehensive Cancer Center (CCC).

KI and Cancer Research Horizons announce 5-year partnership
探花精选 and Cancer Research UK鈥檚 innovation engine, Cancer Research Horizons, have established a 5-year strategic partnership in November 2022, dedicated to accelerating the translation of academic cancer research into improved treatments for patients.
Events, Seminars and Workshops

Industry-Academia Collaborations Seminar Series on Artificial Intelligence (AI)
The Power of AI in Oncology and Healthcare
How can researchers and companies work together to drive innovation in health and AI? Join us for an insightful event where experts share their experiences on industry-academia collaboration, intellectual property strategies, and the practical implementation of AI in healthcare. Gain valuable perspectives on accelerating research impact, simplifying imaging and AI in cancer studies, and navigating the IP landscape for successful partnerships.
Date: 26 March 2025
Time: 14:45 ( starts at 15:00)
Speakers: Elisabeth Epstein, Frantzeska Papadopoulou Skarp, Johanna Furuhjelm, and Fredrik Illerstam. The presentations will be followed by an after work. for the event.
Registration: Please, for the seminar and after work.
This seminar is a joint collaboration between Cancer Research KI and KI Science Park.

Karolinska CCC Day 2025
The Karolinska CCC Day will take place on 31 March 2025.
Registration is now open!
The event is free, but registration is required. You can . Don't forget to sign up for the poster session when you register. There will be a prize for the best poster!
Registration and abstract submission deadline: 19 March 2025
More information about the program will come soon.

Radiotherapy Workshop with the National Institute of Oncology Budapest
Save the date for the second radiotherapy workshop in Stockholm within the framework of the "twinning agreement" between KI and NIO. The workshop will cover radiotherapy (RT) related research ongoing at Karolinska University Hospital, KI and NIO. It will cover several topics such as brachytherapy, SBRT, clinical RT trials and preclinical RT research.
Date: 12-13 May 2025
Information about the program and registration will follow.

7th Cancer Swedish Research Meeting in Malm枚
Register for the up-coming Swedish Cancer Research Meeting 22-23 May 2025 in Malm枚!
Extended Abstract Submission Deadline!!! Please by 14th March 2025.
The meeting is open to all clinical, preclinical researchers and others with an interest in cancer research from the organizing universities.
The four keynote speakers are Douglas Hanahan, Jana de Boniface, Anna Blom, and Julian Downward. The meeting hosts plenary sessions on the themes: Immunotherapy, Prevention and Biomarker Implementation.
Abstract submission deadline: The deadline for abstract submission is 14th March 2025.
Venue: Clarion Hotel & Congress Malm枚 Live
Host: Lund University Cancer Centre
Organizers: Lund University Cancer Centre - LUCC, 探花精选 - Cancer Research KI, Uppsala & Ume氓 Universities 鈥 U-CAN, University of Gothenburg - Sahlgrenska Center for Cancer Research - SCCR, Link枚ping University 鈥 Link枚ping Cancer Center - LCC
Grant Announcements

Collaborative Call to Support Cancer Research - Mayo Clinic and Cancer Research KI 2025
The Mayo Clinic Comprehensive Cancer Center (MCCCC) and Cancer Research 探花精选 (CRKI) are pleased to announce the 2025 Request for Applications (RFA) within the areas of breast cancer, other solid tumors, and hematologic malignancies with a submission deadline of April 4, 2025.

Therapeutic Catalyst Grant
Cancer Research UK Therapeutic Catalyst Awards were launched in late 2021 and have been a great success. The scheme operates as a collaborative venture between research scientists and drug discoverers within Cancer Research Horizons to accelerate the translation of novel ideas for therapeutic discovery. Awards can be up to 拢250,000 to support a 12鈥18-month proposal. There are 3 rounds of applications per year held in February, June and October.
Next expression of interest deadline: 6 June 2025.